Výsledky vyhledávání - "Hans Bentzen"

Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3

Publikováno v: Eskelund, C W, Dimopoulos, K, Kolstad, A, Glimelius, I, Räty, R, Gjerdrum, L M R, Sonnevi, K, Josefsson, P, Nilsson-ehle, H, Bentzen, H H N, Fagerli, U M, Kuittinen, O, Haaber, J, Niemann, C U, Pedersen, L B, Larsen, M T, Geisler, C H, Hutchings, M, Jerkeman, M & Grønbæk, K 2021, ' Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials: MCL2 and MCL3 ', HemaSphere, vol. 5, no. 1, e510, pp. 1-9 . https://doi.org/10.1097/HS9.0000000000000510
Eskelund, C W, Dimopoulos, K, Kolstad, A, Glimelius, I, Räty, R, Gjerdrum, L M R, Sonnevi, K, Josefsson, P, Nilsson-Ehle, H, Bentzen, H H N, Fagerli, U M, Kuittinen, O, Haaber, J, Niemann, C U, Pedersen, L B, Larsen, M T, Geisler, C H, Hutchings, M, Jerkeman, M & Grønbæk, K 2021, ' Detailed Long-Term Follow-Up of Patients Who Relapsed After the Nordic Mantle Cell Lymphoma Trials : MCL2 and MCL3 ', HemaSphere, vol. 5, no. 1, pp. e510 . https://doi.org/10.1097/HS9.0000000000000510
HemaSphere, Vol 5, Iss 1, p e510 (2021)
HemaSphere

Mantle cell lymphoma (MCL) is an incurable disease with a highly variable clinical course. The prognosis after relapse is generally poor, and no standard of care exists. We investigated the postrelapse outcomes of 149 patients who were initially trea

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ee286fc06e4569f4fe9d12f07f33ac5
https://curis.ku.dk/portal/da/publications/detailed-longterm-followup-of-patients-who-relapsed-after-the-nordic-mantle-cell-lymphoma-trials-mcl2-and-mcl3(14588b5c-dc30-434b-a78a-e3b55e67478f).html

Zobrazit plný text záznamu

Real world data on histological transformation in patients with follicular lymphoma:incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort

Autor: Pär Josefsson, Bodil Himmelstrup, Torben Plesner, Maja Ludvigsen, Judit Jørgensen, Hans Bentzen, Francesco d'Amore, Trine Lindhardt Plesner, Tine Litske Bennedsen, Ida Blok Sillesen, Charlotte Madsen

Publikováno v: Madsen, C, Plesner, T L, Bentzen, H H N, Jørgensen, J M, Sillesen, I B, Himmelstrup, B M, Josefsson, P, Plesner, T, Bennedsen, T L, Ludvigsen, M & d'Amore, F A 2020, ' Real world data on histological transformation in patients with follicular lymphoma : incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort ', Leukemia and Lymphoma, vol. 61, no. 11, pp. 2584-2594 . https://doi.org/10.1080/10428194.2020.1779254
Madsen, C, Plesner, T L, Bentzen, H H, Jørgensen, J, Sillesen, I B, Himmelstrup, B M, Josefsson, P, Plesner, T, Bennedsen, T L, Ludvigsen, M & d’Amore, F A 2020, ' Real world data on histological transformation in patients with follicular lymphoma : incidence, clinico-pathological risk factors and outcome in a nationwide Danish cohort ', Leukemia and Lymphoma, vol. 61, no. 11, pp. 2584-2594 . https://doi.org/10.1080/10428194.2020.1779254

We investigated incidence, risk factors and outcome for follicular lymphoma (FL) patients with histologic transformation (HT) found at primary diagnosis (discordant/composite, dc-tFL) or sequentially (s-tFL). Between 2000 and 2015, 2773 patients were

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afb7062596091b4270c44cd7ba397e52
https://pure.au.dk/portal/da/publications/real-world-data-on-histological-transformation-in-patients-with-follicular-lymphoma(fcd0fbaa-78e2-4861-8ef8-0b3380cbbc4b).html

Zobrazit plný text záznamu

Richter's transformation in patients with chronic lymphocytic leukaemia:a Nationwide Epidemiological Study

Autor: Michael Roost Clausen, Lisbeth Enggaard, Christian Brieghel, Michael A. E. Andersen, Marie Helleberg, Robert Schou Pedersen, Christian Bjørn Poulsen, Hans Bentzen, Caspar da Cunha-Bang, Mikael Frederiksen, Henrik Frederiksen, Carsten Utoft Niemann, Ilse Christiansen, Yasmin Ben-Dali, Linda Højberg Nielsen, Erik Clasen-Linde, Mariam Hussein Hleuhel

Publikováno v: Ben-Dali, Y, Hleuhel, M H, da Cunha-Bang, C, Brieghel, C, Poulsen, C B, Clasen-Linde, E, Bentzen, H H N, Frederiksen, H, Christiansen, I, Nielsen, L H, Enggaard, L, Helleberg, M, Clausen, M, Frederiksen, M, Pedersen, R S, Niemann, C U & Andersen, M A 2020, ' Richter's transformation in patients with chronic lymphocytic leukaemia : a Nationwide Epidemiological Study ', Leukemia and Lymphoma, vol. 61, no. 6, pp. 1435-1444 . https://doi.org/10.1080/10428194.2020.1719092
Ben-Dali, Y, Hleuhel, M H, da Cunha-Bang, C, Brieghel, C, Poulsen, C B, Clasen-Linde, E, Bentzen, H H N, Frederiksen, H, Christiansen, I, Nielsen, L H, Enggaard, L, Helleberg, M, Clausen, M, Frederiksen, M, Pedersen, R S, Niemann, C U & Andersen, M A 2020, ' Richter’s transformation in patients with chronic lymphocytic leukaemia : a Nationwide Epidemiological Study ', Leukemia and Lymphoma, vol. 61, no. 6, pp. 1435-1444 . https://doi.org/10.1080/10428194.2020.1719092

Richter’s transformation (RT) refers to the development of an aggressive lymphoma in patients with chronic lymphocytic leukemia (CLL). Approximately, 2–10% of patients with CLL develop RT, most often as diffuse large B-cell lymphoma. To assess th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::331fc0ea218fb657fa665d31d9a741b6
https://portal.findresearcher.sdu.dk/da/publications/24171470-f3c5-4dc9-b6d9-5c9a60703580

Zobrazit plný text záznamu

The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor

Autor: Michael Roost Clausen, Alexander Lindholm d'Amore, Peter Kamper, Maja D. Andersen, Francesco d'Amore, Hans Bentzen

Publikováno v: Andersen, M D, Kamper, P, d’Amore, A, Clausen, M, Bentzen, H & d'Amore, F 2018, ' The incidence of bleomycin induced lung toxicity is increased in Hodgkin lymphoma patients over 45 years exposed to granulocyte-colony stimulating growth factor † ', Leukemia and Lymphoma . https://doi.org/10.1080/10428194.2018.1515939

In Hodgkin lymphoma (HL) bleomycin can induce pulmonary toxicity (BPT). BPT consists of respiratory tract symptoms during bleomycin-exposure and radiologic pulmonary lesions without concomitant infection. Older age, bleomycin dose, smoking history an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddedf5611eddccc0bf76c3bc860a3bf2
https://doi.org/10.1080/10428194.2018.1515939

Zobrazit plný text záznamu

Subcutaneous Epcoritamab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Preliminary Results from the Epcore CLL-1 Trial

Autor: Hans Bentzen, Tommy Li, Arnon P. Kater, Jacob Haaber Christensen, Jenny Chen, Carsten Utoft Niemann, Marcia Rios, Martin Hutchings, Tammy Palenski, Anthony R. Mato

Publikováno v: Kater, A P, Christensen, J H, Bentzen, H H, Niemann, C U, Hutchings, M, Chen, J, Rios, M, Palenski, T, Li, T & Mato, A R 2021, ' Subcutaneous Epcoritamab in Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia: Preliminary Results from the Epcore CLL-1 Trial ', Blood, vol. 138, no. Supplement 1, 2627 . https://doi.org/10.1182/blood-2021-146563

Background: Small molecules such as Bruton tyrosine kinase (BTK) and B-cell lymphoma 2 (BCL2) inhibitors have transformed the management of chronic lymphocytic leukemia (CLL). However, such treatments are not curative, and patients (pts) with relapse

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5154871638a5c569e50f0bbc50f6f894
https://doi.org/10.1182/blood-2021-146563

Zobrazit plný text záznamu

Up-front rituximab maintenance improves outcome in patients with follicular lymphoma : a collaborative Nordic study

Autor: Sirpa Leppä, Ida Blok Sillesen, Maja Ludvigsen, Judit Jørgensen, Hans Bentzen, Charlotte Madsen, T. Kuismanen, Annika Pasanen, Trine Lindhardt Plesner, Michael Roost Clausen, K. R. Jensen, Dorthe Rønnov-Jessen, Bodil Himmelstrup, Francesco d'Amore, A. M. Pettinger

Publikováno v: Madsen, C, Clausen, M R, Plesner, T L, Pasanen, A, Kuismanen, T, Bentzen, H H, Jørgensen, J M, Sillesen, I B, Himmelstrup, B M, Rønnov-Jessen, D, Jensen, K R, Pettinger, A M, Ludvigsen, M, Leppä, S & d'Amore, F A 2018, ' Up-front rituximab maintenance improves outcome in patients with follicular lymphoma : a collaborative Nordic study ', Blood advances, vol. 2, no. 13, pp. 1562-1571 . https://doi.org/10.1182/bloodadvances.2018017673
Madsen, C, Clausen, M R, Plesner, T L, Pasanen, A, Kuismanen, T, Bentzen, H H, Jørgensen, J M, Sillesen, I B, Himmelstrup, B M, Rønnov-Jessen, D, Jensen, K R, Pettinger, A M, Ludvigsen, M, Leppä, S & d'Amore, F A 2018, ' Up-front rituximab maintenance improves outcome in patients with follicular lymphoma : a collaborative Nordic study ', Blood Advances, vol. 2, no. 13, pp. 1562-1571 . https://doi.org/10.1182/bloodadvances.2018017673

The introduction of the anti-CD20 antibody rituximab in combination with chemotherapy (R-chemo) has improved the prognosis of patients with follicular lymphoma (FL). During the last decade, the addition of a maintenance treatment with rituximab (MR)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f06ef0ed1b92d207d5de5f59813f1bf
http://hdl.handle.net/10138/299379

Zobrazit plný text záznamu

Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma

Autor: Trung Hieu Do, Paw Jensen, Rie S. Bech, Peter Braendstrup, Thomas Stauffer Larsen, Hans Bentzen, N. George Mikhaeel, Line Stensig Lynggaard, Hans Erik Johnsen, Jessica L. Brady, Tarec Christoffer El-Galaly, Kasper Lindblad Nielsen, Karen Dybkær, Martin Bøgsted

Publikováno v: Bech, R S, Nielsen, K L, Larsen, T S, Bentzen, H, Lynggaard, L S, Do, T H, Braendstrup, P, Brady, J, Mikhaeel, N G, Dybkaer, K, Johnsen, H E, Jensen, P, Bøgsted, M & El-Galaly, T C 2018, ' Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma ', British Journal of Haematology, vol. 182, no. 2, pp. 297-301 . https://doi.org/10.1111/bjh.14775
Bech, R S, Nielsen, K L, Larsen, T S, Bentzen, H H N, Lynggaard, L S, Do, T H, Braendstrup, P, Brady, J, Mikhaeel, N G, Dybkaer, K, Johnsen, H E, Jensen, P, Bøgsted, M & El-Galaly, T C 2018, ' Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma ', British Journal of Haematology, vol. 182, no. 2, pp. 297-301 . https://doi.org/10.1111/bjh.14775
Bech, R S, Nielsen, K L, Larsen, T S, Bentzen, H H, Lynggaard, L S, Do, T H, Braendstrup, P, Brady, J, Mikhaeel, N G, Dybkaer, K, Johnsen, H E, Jensen, P, Bøgsted, M & El-Galaly, T C 2018, ' Real world data on rituximab maintenance therapy after frontline immunochemotherapy in grade 1-3a follicular lymphoma ', British Journal of Haematology, vol. 182, no. 2, pp. 297-301 . https://doi.org/10.1111/bjh.14775

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06afdd30687d77452edda0a0bd59fe06
https://portal.findresearcher.sdu.dk/da/publications/fa8a6b82-f3d1-4d80-afbf-e363e0dea757

Zobrazit plný text záznamu

SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma

Autor: Camilla Darum Sørensen, Charlotte Guldborg Nyvold, Anita Tranberg Simonsen, Marie Schou, Hans Bentzen

Publikováno v: Simonsen, A T, Schou, M, Sørensen, C D, Bentzen, H H N & Nyvold, C G 2015, ' SOX11, CCND1, BCL1/IgH and IgH-VDJ: a battle of minimal residual disease markers in mantle cell lymphoma ', Leukemia and Lymphoma, vol. 56, no. 9, pp. 2724-2727 . https://doi.org/10.3109/10428194.2015.1004672

Minimal residual disease (MRD) is defined as the persistence of residual tumor cells in patients during or after treatment, when the patient is in remission. The monitoring of MRD has been shown to...

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43c56cac5eb18fb791339fa41e69f464
https://pure.au.dk/portal/da/publications/sox11-ccnd1-bcl1igh-and-ighvdj-a-battle-of-minimal-residual-disease-markers-in-mantle-cell-lymphoma(2f820495-afe3-45ec-853f-8bf2a840005d).html

Zobrazit plný text záznamu

Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure

Autor: Hans BENTZEN, Robert S. PEDERSEN, Henrik B. PEDERSEN, Ole NYVAD, Erling B. PEDERSEN

Publikováno v: Bentzen, H, Pedersen, R S, Pedersen, H B, Nyvad, O & Pedersen, E B 2003, ' Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure ', Clinical Science, vol. 104, no. 3, pp. 303-312 .

The purpose of this study was to clarify whether the secretions of atrial natriuretic peptide (ANP) and brain natriuretic peptide (BNP) are pulsatile in patients with chronic heart failure (CHF), and whether the rhythmic oscillations for ANP and BNP

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0223017d4e2ec2365618abbe3a6733b4
https://doi.org/10.1042/cs1040303

Zobrazit plný text záznamu

A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait

Autor: Anne O. Gang, Martin Hutchings, Karen Dybkær, Tarec Christoffer El-Galaly, Hans Bentzen, Hans Erik Johnsen, Robert Schou Pedersen, Martin Bøgsted, Syed Azhar Ahmad, Anders Ellern Bilgrau, Berit Jamie Nielsen, Karen Juul Mylam, Peter de Nully Brown, Lars Møller Pedersen, Olav J. Bergmann, Maja Bech Juul

Publikováno v: El-Galaly, T C, Bilgrau, A E, de Nully Brown, P, Juul Mylam, K, Ahmad, S A, Pedersen, L M, Gang, A O, Bentzen, H H, Juul, M B, Bergmann, O J, Pedersen, R S, Nielsen, B J, Johnsen, H E, Dybkaer, K, Bøgsted, M & Hutchings, M 2015, ' A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait ', British Journal of Haematology, vol. 169, no. 3, pp. 435-444 . https://doi.org/10.1111/bjh.13316
El-Galaly, T C, Bilgrau, A E, de Nully Brown, P, Mylam, K J, Ahmad, S A, Pedersen, L M, Gang, A O, Bentzen, H H, Juul, M B, Bergmann, O J, Pedersen, R S, Nielsen, B J, Johnsen, H E, Dybkær, K, Bøgsted, M & Hutchings, M 2015, ' A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait ', British Journal of Haematology, vol. 169, no. 3, pp. 435-444 . https://doi.org/10.1111/bjh.13316

Watch and wait (WAW) is a common approach for asymptomatic, advanced stage follicular lymphoma (FL), but single-agent rituximab is an alternative for these patients. In this nationwide study we describe the outcome of patients selected for WAW. A coh

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf05638d17234ceccfc979973d1415c
https://pubmed.ncbi.nlm.nih.gov/25709094

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání